Euthymics Bioscience
  • Home
  • Our Programs
    • MAJOR DEPRESSIVE DISORDER AND AMITIFADINE
    • ADHD and EB-1020
  • Our Technology
  • About
    • About Euthymics
    • Management
    • Board of Directors
  • Contact
  • News

News

  • News
    • Corporate Fact Sheet
    • In The News
    • Press Releases
    • Publications
Home    >    In The News

In The News

February 22nd - Clinical investigator Dr. Donald Garcia discusses the TRIADE study on Austin’s NBC affiliate KXAN


February 15th - Clinical investigator Dr. Ronald Fuchs discusses TRIADE and amitifadine on Philadelphia’s 6 ABC


February 7th - TRIADE clinical investigator Dr. Riaz Baber discusses the trial and amitifadine in the Naperville Sun


January 15th - Dr. Michael Downing, TRIADE clinical investigator, discusses depression and amitifadine on Dallas’ DFW Closeup


December 13th - TRIADE investigator Dr. Eugene DuBoff discusses depression and Euthymics’ amitifadine in The Denver Post


December 5th - Euthymics Featured in BioCentury Emerging Company Profile


November 23rd - TRIADE clinical trial investigator Dr. Kashinath Yadalam discusses TRIADE and Euthymics’ amitifadine on Lake Charles, LA’s KPLC


October 20th - Dr. M. Lane Peyton, TRIADE clinical investigator, discusses the trial and Euthymics’ amitifadine on Oklahoma City’s KFOR News Channel 4


September 12th - TRIADE clinical trial investigator Dr. Eugene DuBoff discusses TRIADE and Euthymics’ amitifadine on Denver, Colorado’s KMGH Channel 7.


Privacy Policy  |  Terms of Use Copyright ©2012 Euthymics Bioscience. All Rights Reserved.